Proxima
PrivateLast Round
Seed
Jan 13, 2026
Total Funding Raised
$80.33M
Company Overview
Proxima is a biotechnology company that provides an AI-driven drug discovery platform for proximity therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxima Comps
Public and private peers based on sector, stage, and business model.
Proxima Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 13, 2026 | ||||
| Pre Seed | Oct 10, 2024 | ||||
| Grant | May 24, 2023 |
Proxima Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Seed |
| Medical Research Future Fund | Grant |
| Braidwell | Seed |
| Magnetic Ventures | Seed |
| NVentures | Seed |
| Yosemite | Seed |
| Alexandria Venture Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Launched Neo-1, an all-atom foundation model for molecular generation.
- Mar 5, 2026
Dr. Juri Rappsilber joins the Scientific Advisory Board.
Proxima Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proxima's valuation, stock price, and market status.
